semaglutide and general anesthesia Doctors warn some popular weight-loss drugs may raise risk of complications under Are Serious Anesthesia Risks of

2020;67:e28085

10.1002/pds.677 29 FamularoG.GasbarroneL.MinisolaG

[DOI] [PubMed] [Google Scholar] 42.Sikiric P., Seiwerth S., Rucman R., Turkovic B., Rokotov D.S., Brcic L., Sever M., Klicek R., Radic B., Drmic D., et al

I talk about libido in the context of hormones and stress and energy, but where does this connect with the diabetes world

Why your prescription purpose doesnt disqualify you: The injury is the same whether you took the drug for diabetes or weight loss The warnings were inadequate for both approved uses The mechanism is identical regardless of indication The failure to warn affected all patients, not just one category In fact, diabetes patients may have stronger arguments: You needed the medication for a serious health condition You had fewer alternatives available The risk-benefit calculation was different You were a captive market with less choice Your claim will focus on: Whether you were adequately informed of gastroparesis risk Whether the severity and potential permanence were disclosed Whether you would have chosen differently if properly warned The damages you suffered as a result Q: What if I took multiple GLP-1 drugs over time

Alguns j indicam que pode haver um efeito rebote, com ganho de peso aps o fim do tratamento, o que tambm pode nortear novos acompanhamentos e alternativas ao tratamento no futuro